This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:celiac [02.17.2019] – [Celiac disease] sallieq | home:diseases:celiac [03.13.2019] – [recent research] sallieq | ||
---|---|---|---|
Line 64: | Line 64: | ||
(({{pubmed> | (({{pubmed> | ||
- | {{tag> | + | Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. |
+ | |||
+ | In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. | ||
+ | |||
+ | {{tag> | ||